Microfluidic-based Tactile Sensor in Cardiac Rehabilitation
1 other identifier
observational
30
1 country
1
Brief Summary
This study will examine the impact of cardiac rehabilitation on blood vessel health using a newly developed microfluidic-based tactile sensor to assess blood vessel health. The participants will have their blood vessel health measured using a sensor that is placed on top of the skin over the artery before and after exercise (1, 3, 5, 10, 30 and 60 mins). The investigators will study these responses at the first session of cardiac rehabilitation and following 1 and 4 weeks of cardiac rehabilitation (sessions 3 and 6). The investigators will also collect some information from the medical record regarding: age, gender, body mass index, resting cardiovascular measures (heart rate, blood pressure etc), medications, reasons which qualified the participant into cardiac rehabilitation, blood tests related to heart or cardiovascular function, metabolic panel, lipid panel, echocardiogram results, recorded electrocardiogram, known vascular diseases, presence of implantable devices, Seattle Heart Failure Model data and cardiovascular measures and exercise workloads during cardiac rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2021
CompletedStudy Start
First participant enrolled
March 20, 2021
CompletedFirst Posted
Study publicly available on registry
March 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2022
CompletedMarch 23, 2021
March 1, 2021
1 year
March 17, 2021
March 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Micro-tactile sensor assessment of arterial stiffness change to exercise
Elasticity (unit measure: pascal) of arterial wall will be assessed.
The change of up to 1 hour post exercise relative to pre-exercise, at 0 weeks, 1 week and 4 weeks of cardiac rehabilitation
Micro-tactile sensor assessment of arterial viscosity change to exercise
Damping (unit measure: pascal x sec) of the arterial wall will be assessed.
The change of up to 1 hour post exercise relative to pre-exercise, at 0 weeks, 1 week and 4 weeks of cardiac rehabilitation
Micro-tactile sensor assessment of arterial radius change to exercise
Size of the artery lumen (unit measure: mm) will be assessed.
The change of up to 1 hour post exercise relative to pre-exercise, at 0 weeks, 1 week and 4 weeks of cardiac rehabilitation
Automated blood pressure device assessment of systolic and diastolic blood pressure change to exercise
Systolic and diastolic blood pressure (unit measure: mmHg) of the artery will be assessed.
The change of up to 1 hour post exercise relative to pre-exercise, at 0 weeks, 1 week and 4 weeks of cardiac rehabilitation
Study Arms (1)
Cardiac Rehabilitation
Individuals assigned to phase II (outpatient) cardiac rehabilitation program will undergo their normal exercise routines while the investigators make the measurements pre and post exercise at 0 week, and following 1 and 4 weeks of exercise.
Eligibility Criteria
Individuals who are undergoing Phase II (outpatient) cardiac rehabilitation at Sentara Heart Hospital (Norfolk, Va) and meet the inclusion and exclusion criteria listed will be recruited for the study.
You may qualify if:
- Age 45-70
- Subjects who qualify for cardiac rehabilitation via doctor's orders
You may not qualify if:
- ●Physical limitations which would preclude one from performing exercise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhili haolead
- Eastern Virginia Medical Schoolcollaborator
Study Sites (1)
Sentara Heart Hospital
Norfolk, Virginia, 23501, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julie Hao, Ph.D.
Old Dominion University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 17, 2021
First Posted
March 23, 2021
Study Start
March 20, 2021
Primary Completion
March 20, 2022
Study Completion
March 20, 2022
Last Updated
March 23, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share